All Type of News
Flexible management of pharmaceutical product reassessment under adoption of the Pharmaceutical Product Renewal System
Under adoption of the Pharmaceutical Product Renewal System, regulations related to this have been revised so that these products can be reassessed only when it is necessary, instead of regularly.
The Ministry of Foo...
Celltrion, Pharma Research, Whan In & Samjin record highest collective operating profit/sales rate in order
The KOSDAQ listed pharmaceutical companies’ year-on-year increase rate of operating profits on average is about twice higher than the one of KOSPI listed pharmaceutical companies. In regards to the collective 3rd quar...
Kwang Dong signs a Korean exclusive license agreement of female sexual desire disorder treatment
Kwang Dong Pharmaceutical(CEO Sung-Won Choi) announced on the 22nd that it signed a Korean exclusive license agreement of ‘bremelanotide,’ a substance candidate of novel drug developed by U.S. Palatin Technologies for...
Green Cross wins largest blood product tender ever
Green Cross has drawn the largest exports of blood product ever.
Green Cross(CEO Eun-Cheol Huh) announced on the 22nd that the company obtained an order of IV-Globulin SN(IVIG-SN) worth of USD 42.9 million(KRW 47 bil...
“Gleevec generics have no bioequivalent problem, and prescribing is a matter of the medical field”
The Ministry of Food and Drug Safety(MFDS) made straight that there was no problem for the Gleevec generics’ bioequivalence test in safety and efficacy, but prescribing generics over Gleevec is not a matter of issue t...
How much did listed pharmaceutical companies spend on SG&A expenses?
This year, the increase of collective selling, general & administrative(SG&A) expenses by the 3rd quarter of the year on average was 20 times higher in the KOSDAQ market than the one in the KOSPI. When it comes to the...
Pharmaceutical companies’ concerns over ‘Financial Gain & Expenditure Report’ even before it starts
While being active in preparing for the ‘Financial Gain & Expenditure Report’ which will be implemented from 1 January 2018, pharmaceutical companies have encountered a new concern.
When the report became obligated, ...
Distribution industry opposes to pharmaceutical company sending back returned medicines without shipping record
The pharmaceutical distribution industry has strong opposed to pharmaceutical companies which cut off returning stored medicines in a self-interested fashion in regards to the serial number system.
According to the i...
Chairman Sun-Hye Cho, “I’ll lead coexistence with the idea of ‘strong association’”
Geo-Young Chairman Sun-Hye Cho formalized to run for the 35th Korea Pharmaceutical Distribution Association Presidential Election.
At a meeting with Yakup Shinmoon on the 21st, Chairman Sun-Hye Cho said “The pharmace...
Where are biotech companies at in ‘cutting-edge biologic development’
Under the ‘Global High-Tech Biotechnology Development Project’ that the Ministry of Science and ICT and the Ministry of Health and Welfare have carried out as a part of the plan to raise world-class biotech companies,...
